Trial intelligence / Profile preview

Shorter treatment for minimal tuberculosis in children

PACTR201505001141379Not yet recruiting

Sponsor
University College London
Start
Jul 2015
Countries
4
01

Overview

Randomised, open-label trial in Tuberculosis (TB) (2 arms), sponsored by University College London. Primary endpoint: TB disease-free survival at 72 weeks post-randomization. Planned start Jul 2015; status: not yet recruiting.

02

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on PACTR201505001141379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201505001141379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call